Table I.
Baseline characteristics of The Cancer Genome Atlas patients with cervical cancer treated with or without radiotherapy.
| Clinical characteristics | Without radiotherapy (N=64) | With radiotherapy (N=174) | P-value |
|---|---|---|---|
| Age, years, mean ± SD | 45.09±11.49 | 49.01±14.19 | 3.12×10−2a |
| Pathologic M (M0/M1/NA) | 29/1/34 | 57/9/108 | 1.65×10−1b |
| Pathologic N (N0/N1/NA) | 45/7/12 | 58/35/81 | 2.15×10−3b |
| Pathologic T (T1/T2/T3/T4/NA) | 47/9/0/4/4 | 62/46/17/5/44 | 1.902×10−5b |
| Pathologic stage (I/II/III/IV/NA) | 49/8/2/4/1 | 78/47/29/16/4 | 9.842×10−5b |
| Pathologic grade (1/2/3/4/NA) | 6/27/26/0/5 | 10/79/66/1/18 | 6.92×10−1b |
| Smoking (reformed/current/never/NA) | 7/12/38/7 | 33/43/86/12 | 2.06×10−2b |
| New tumor (yes/no/-) | 51/12/1 | 31/142/1 | 2.20×10−16b |
| Targeted molecular therapy (yes/no/NA) | 5/25/34 | 127/37/10 | 3.164×10−10b |
| Death (dead/alive) | 15/49 | 51/123 | 4.17×10−1b |
| Overall survival months, mean ± SD | 35.11±43.03 | 38.75±38.92 | 5.54×10−1a |
a
Student's t test.
b
Fisher's exact test. NA, not available; SD, standard deviation.